Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteomics in cancer vaccine development.

Stacy H Shoshan1, Arie Admon

  • 1Technion-Israel Institute of Technology, Department of Biology, Haifa 32000, Israel. sshoshan@tx.technion.ac.il

Expert Review of Proteomics
|May 17, 2005
PubMed
Summary

Proteomics identifies cancer-specific proteins and peptides for potential cancer vaccines. While technologies have successfully identified tumor markers, clinical application of these vaccine candidates is pending.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Innovative CRISPR/Cas9-Based Strategy for Allele-Specific HLA Peptidome Analysis Using a Pan-HLA Antibody.

Molecular & cellular proteomics : MCP·2026
Same author

Closer Peptide Repertoire Similarity of HLA-B∗14:03 and HLA-B∗27:05 Sheds Light on Ankylosing Spondylitis Susceptibility.

Molecular & cellular proteomics : MCP·2025
Same author

Analysis of the ubiquitin-modified proteome identifies novel host factors in Kaposi's sarcoma herpesvirus lytic reactivation.

Journal of virology·2024
Same author

TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis.

Arthritis research & therapy·2024
Same author

Phosphorylation of PP2Ac by PKC is a key regulatory step in the PP2A-switch-dependent AKT dephosphorylation that leads to apoptosis.

Cell communication and signaling : CCS·2024
Same author

Differential Modulation of the Phosphoproteome by the MAP Kinases Isoforms p38α and p38β.

International journal of molecular sciences·2023

Area of Science:

  • Proteomics
  • Cancer Research
  • Immunology

Background:

  • Proteomics enables large-scale characterization of proteins in biological systems.
  • It identifies differences in protein expression and post-translational modifications.
  • These capabilities are valuable for cancer research and vaccine development.

Purpose of the Study:

  • To explore the application of proteomics in identifying cancer vaccine candidates.
  • To highlight the role of proteomics in discovering tumor markers.
  • To assess the current status of proteomics-driven cancer vaccine development.

Main Methods:

  • Utilizing key proteomics technologies such as 2D polyacrylamide gel electrophoresis, multidimensional high-performance liquid chromatography, mass spectrometry, and protein arrays.
  • Analyzing various biological samples including cancer cell cultures, tumor tissues, human leukocyte antigen peptides, and serum.
  • Employing serologic proteomics to detect cancer-specific antibodies.

Main Results:

  • Proteomics technologies have successfully identified tumor markers from diverse biological samples.
  • Proteins and peptides exclusively or preferentially expressed in cancer cells were identified as potential vaccine candidates.
  • The identified markers show promise for targeted cancer therapies.

Conclusions:

  • Proteomics is a powerful tool for discovering novel cancer vaccine candidates.
  • The identified tumor markers represent a significant advancement in cancer diagnostics and therapeutics.
  • Further clinical validation is required to translate proteomics-identified vaccine candidates into effective treatments.

Related Experiment Videos